| DYS000-Qualifying Exam | | | | | | | | | | | |
| FKL602-Molecular Pharmacology | 3 | 2 | 3 | 2 | 2 | 2 | 1 | 3 | 3 | 1 | 3 |
| FKL608-Cardiovascular Pharmacology | 3 | 0 | 3 | 3 | 0 | 3 | 3 | 3 | 3 | 3 | 0 |
| FKL609-Biochemical Pharmacology | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
| FKL610-Drug interactions | 3 | 0 | 3 | 3 | 0 | 3 | 1 | 3 | 3 | 3 | 0 |
| FKL612-Central Nervous System Drugs | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 1 |
| FKL620-Immunopharmacology | 3 | 1 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 2 |
| FKL621-Experimental Pharmacology II | | | | | | | | | | | |
| FKL624-Digital Applications in Pharmacology | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| FKL625-Gene Transfere Methods | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| FKL626-Pharmacovigilance and Human Pharmacology | 3 | 2 | 3 | 3 | 0 | 3 | 1 | 3 | 3 | 3 | 0 |
| FKL631-Perinatal and Pediatric Pharmacology | | | | | | | | | | | |
| FKL632-Endocrine Pharmacology | 3 | 2 | 2 | 2 | 2 | 3 | 1 | 2 | 3 | 2 | 1 |
| FKL633-Geriatric Pharmacology | | | | | | | | | | | |
| FKL634-Drug Originated Diseases | 3 | 2 | 2 | 2 | 2 | 3 | 1 | 3 | 2 | 3 | 3 |
| FKL635-Neurodegenerative Diseases | | | | | | | | | | | |
| TEZ900-Thesis | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| UZM900-Research in Area of Specialization | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |